• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VTA
Click for more information
0.00% $15.60

VITERRA INC

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
VTA
Ann: Removal from Official List at close 18/12/20 		18/12/12 0 463
18/12/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  463 
VTA
Ann: Suspension from Official Quotation 		11/12/12 0 298
11/12/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  298 
VTA
Ann: Closing Timeline Agreement 		11/12/12 0 332
11/12/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  332 
VTA
Ann: Glencore receives MOFCOM approval for Viterr 		10/12/12 0 462
10/12/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  462 
VTA
Ann: Letter Agreement 		12/11/12 0 397
12/11/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  397 
VTA
Ann: Viterra provides further update on Glencore 		12/11/12 0 199
12/11/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  199 
VTA
Ann: Letter Agreement 		27/09/12 0 237
27/09/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  237 
VTA
Ann: Viterra Provides Update on Glencore Transact 		27/09/12 0 214
27/09/12 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  214 

See All Discussions arrow Created with Sketch.

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

If you've been following the Chinese economy this year, you'd know that the country has been trying to stimulate all year.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
ACCC seeks Olam divestments before it can buy Namoi Cotton Australia's market regulator the ACCC has expressed further concerns about the potential takeover of Namoi Cotton by Olam Agri.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico? De Grey Mining on Friday denied reports that it's received a takeover offer from Canada-based Agnico Eagle.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.